CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of growth hormone–releasing hormone (GHRH) engineered with a DAC modification to significantly extend its half-life. In laboratory studies, this extended duration allows for investigations into sustained growth hormone release, receptor binding, and long-term peptide stability under controlled conditions.

Key Details

• Form: Lyophilized powder

• Purity: ≥98% (HPLC verified)